A Proposed Revision of the Stepwise Treatment Algorithm in Asthma

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2021 Mar 31

PMID 33789069

Citations 1

Authors

Richard Beasley

Pepa Bruce

Lee Hatter

Irene Braithwaite

Alex Semprini

Cilein Kearns

Mark Weatherall

Ian D Pavord

Affiliations

Soon will be listed here.

Citing Articles

The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma.

Hatter L, Bruce P, Holliday M, Anderson A, Braithwaite I, Corin A ERJ Open Res. 2021; 7(4).

PMID: 34853785 PMC: 8628747. DOI: 10.1183/23120541.00271-2021.

References

Sobieraj D, Weeda E, Nguyen E, Coleman C, White C, Lazarus S . Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018; 319(14):1485-1496. PMC: 5876810. DOI: 10.1001/jama.2018.2769. View

Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord I . Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med. 2019; 199(12):1471-1477. DOI: 10.1164/rccm.201810-1868CI. View

Beasley R, Braithwaite I, Semprini A, Kearns C, Weatherall M, Pavord I . Optimal Asthma Control: Time for a New Target. Am J Respir Crit Care Med. 2020; 201(12):1480-1487. DOI: 10.1164/rccm.201910-1934CI. View

Patel M, Pilcher J, Reddel H, Qi V, Mackey B, Tranquilino T . Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma. J Allergy Clin Immunol Pract. 2014; 2(6):751-8. DOI: 10.1016/j.jaip.2014.06.001. View

Rogliani P, Ritondo B, Ora J, Cazzola M, Calzetta L . SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis. Eur Respir J. 2020; 56(3). DOI: 10.1183/13993003.00625-2020. View

Pavord I, Beasley R, Agusti A, Anderson G, Bel E, Brusselle G . After asthma: redefining airways diseases. Lancet. 2017; 391(10118):350-400. DOI: 10.1016/S0140-6736(17)30879-6. View

Beasley R, Beckert L, Fingleton J, Hancox R, Harwood M, Hurst M . Asthma and Respiratory Foundation NZ Adolescent and Adult Asthma Guidelines 2020: a quick reference guide. N Z Med J. 2020; 133(1517):73-99. View

OByrne P, FitzGerald J, Bateman E, Barnes P, Zheng J, Gustafson P . Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study. Lancet Respir Med. 2020; 9(2):149-158. DOI: 10.1016/S2213-2600(20)30416-1. View

Beasley R, Braithwaite I, Semprini A, Kearns C, Weatherall M, Harrison T . ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma. Eur Respir J. 2020; 55(1). DOI: 10.1183/13993003.01407-2019. View

10.

Heaney L, Busby J, Hanratty C, Djukanovic R, Woodcock A, Walker S . Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Lancet Respir Med. 2020; 9(1):57-68. PMC: 7783382. DOI: 10.1016/S2213-2600(20)30397-0. View